Meet Craig Kovitz, M.D.
Craig A. Kovitz, M.D.
Department of General Oncology, Division of Cancer Medicine
About Dr. Kovitz
Present Title & Affiliation
Primary Appointment
Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Genitourinary Medical Oncology (Joint Appointment), The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
1997 | Mount Sinai School of Medicine, New York, New York, US, MD |
1993 | Cornell University, Ithaca, New York, US, Biological Sciences, BS |
Postgraduate Training
2004-2007 | Fellowship, Medical Oncology Hematology, M.D. Anderson Cancer Center, Houston, Texas |
1998-2000 | Clinical Residency, Internal Medicine, Wilford Hall Medical Center, San Antonio, Texas |
1997-1998 | Clinical Internship, Internal Medicine, Wilford Hall Medical Center, San Antonio, Texas |
Board Certifications
2007 | Hematology; American Board of Internal Medicine |
2007 | Medical Oncology; American Board of Internal Medicine |
2000 | Internal Medicine; American Board of Internal Medicine |
Experience & Service
Academic Appointments
Associate Professor, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2022
Associate Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2022
Associate Medical Director/Medical Oncology, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2012
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013
Administrative Appointments/Responsibilities
Section Chief, Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Quality Officer, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2018 - Present
Chief Fellow, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Teaching Fellow, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2006
Associate Program Director, Department of Internal Medicine Program, Keesler Medical Center, Keesler AFB, MS, 2001 - 2004
Attending Internist, Department of Internal Medicine, Keesler Medical Center, Keesler AFB, MS, 2000 - 2004
Other Appointments/Responsibilities
Medical Oncologist/Hematologist, Millennium Oncology, The Woodlands, TX, 2014 - 2016
Institutional Committee Activities
Member, PRS Faculty Compensation Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Medical Use Safety Team, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, ATC Efficiency Committee, MD Anderson Cancer Center in The Woodlands, 2019 - Present
Member, Houston Area Location (HAL) Quality and Safety Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Chair, Education Subcommittee, Cancer Committee, Christus St. John Hospital; Nassau Bay, TX, 2012 - 2013
Member, Physician Relations Faculty Advisory Board, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Cancer Liaison Physician to American College of Surgeons, Christus St. John Hospital; Nassau Bay, TX, 2011 - 2013
Secretary, Medical Executive Committee, Christus St. John Hospital; Nassau Bay, TX, 2010 - 2011
Member, ATC Efficiency Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present
Member, Fellow Steering Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Honors & Awards
James Felt Memorial Award for Highest Overall Performance During the Four Year Medical Curriculum, Mount Sinai School of Medicine | |
Alpha Omega Alpha Medical Honor Society, Lambda Chapter, Mount Sinai School of Medicine | |
James J. Leonard Award for Excellence in Teaching Internal Medicine, Willford Hall Medical Center/Uniformed University of the Health Sciences | |
Best Teaching Resident; Wilford Hall Medical Center, Lackland AFB, TX | |
Staff Teacher of the Year; Department of Internal Medicine, Keesler Medical Center; Keesler AFB, MS | |
Air Force Commendation Medal, United States Air Force | |
Meritorious Service Medal, United States Air Force | |
General Archie Hoffman Award for Excellence in Academic Medicine, Society of Air Force Physician | |
Waun Ki Hong/Sanofi-Aventis Award for Excellence in Thoracic Oncology, MD Anderson Cancer Center | |
Clifton D. Howe Award for Clinical Excellence, MD Anderson Cancer Center | |
Jesse H. Jones Fellowship in Cancer, MD Anderson Cancer Center | |
Chief Fellow, Medical Oncology/Hematology, MD Anderson Cancer Center | |
MDACC Patient Experience Award: Top 1% Provider, MD Anderson Cancer Center | |
MDACC Patient Experience Award: Top 10% Provider, MD Anderson Cancer Center |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Alhalabi, O, Wilson, NR, Xiao, L, Lin, Y, Khandelwal, J, Moussa, MJ, Msaouel, P, Navai, N, Gao, J, Kamat, A, Pilie, PG, Shah, AY, Goswami, S, Matin, S, Kovitz, CA, Holla, V, Guo, C, Czerniak, BA, Logothetis, CJ, Corn, P, Dinney, CP, Campbell, M, Hansel, DE, Tannir, NM, Siefker-Radtke, AO. Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. European Urology Oncology 6(6):611-620, 2023. PMID: 37833193.
- Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Cohen L, Aparicio A, Zurita AJ, Reuben A, Marmonti E, Chun SG, Reddy JP, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Pilie P, Kovitz C, Du W, Simiele SJ, Kumar R, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn PG. Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial. JAMA Oncol 9(6):825-834, 2023. e-Pub 2023. PMID: 37022702.
- Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB, Phillips RM. Erratum to "Periorbital Edema Associated with Alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596]. Cancer Treat Res Commun:100654. e-Pub 2022. PMID: 36463021.
- Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB, Phillips RM. Periorbital Edema Associated with Alpelisib. Cancer Treat Res Commun 32:100596, 2022. e-Pub 2022. PMID: 35834907.
- Kovitz CA, Bickford D, Ornstein D, Ririe D, Shaughnessy P, Fischer J. Allogeneic Bone Marrow Transplantation at Wilford Hall U.S. Air Force Medical Center: 1987-1999. Mil Med 166(12):1049-53, 2001. PMID: 11778401.
- Kovitz CA, Morgello S. Cerebral Glucose Transporter Expression in HIV Infection. Acta Neuropathol 94(2):140-5, 1997. PMID: 9255388.
Other Articles
- Jain T, Bar M, Kansagra AJ, Chong EA, Hashmi SK, Neelapu SS, Byrne M, Jacoby E, Lazaryan A, Jacobson CA, Ansell SM, Awan FT, Burns L, Bachanova V, Bollard CM, Carpenter PA, DiPersio JF, Hamadani M, Heslop HE, Hill JA, Komanduri KV, Kovitz CA, Lazarus HM, Serrette JM, Mohty M, Miklos D, Nagler A, Pavletic SZ, Savani BN, Schuster SJ, Kharfan-Dabaja MA, Perales MA, Lin Y Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant 25(12):2305-2321, 2019. PMID: 31446199.
- Hughes CL, Yorio JT, Kovitz C, Oki Y Treatment Decisions in a Man with Hodgkin Lymphoma and Guillian-Barré Syndrome: A case report. J Med Case Rep 8:455, 2014. PMID: 25528252.
- Harting M, Tarrant W, Kovitz CA, Rosen T, Harting MT, Souchon E Massive Nodular Melanoma: A case report. Dermatol Online J 13(2):7, 2007. PMID: 17498426.
- Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J Secondary Myelodysplastic Syndromes and Acute Leukemia Developing after Imatinib Mesylate Therapy for Chronic Myeloid Leukemia. Blood 108(8):2811-3, 2006. PMID: 16809614.
Abstracts
- Tang C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Le V, Choi S, Efstathiou E, Wang J, Tu S, Pilie P, Kovitz C, Kumar R, Chapin B, Gomez D, Corn G. Primary analysis of the prostate intermittent hormone basket from EXTEND (External beam radiation to Eliminate Nominal metastatic Disease). A randomized phase II basket trial assessing the efficacy of upfront local consolidative therapy for oligometastatic disease. American Society for Radiation Oncology, 2022. PMID: None.
- Strassburg AD, Kovitz CA. Upper extremity deep venous thromboses at Keesler Medical Center: 1997-2000. J Miss State Med Assoc 43(4):114, 2002. PMID: 11989197.
- Englund K, Kovtiz CA, Turner J. A case of Richter's transformation in chronic lymphcytic leukemia presenting as hypercalcemia and a mediastinal mass. Society of Air Force Physicians Annual Meeting Bulletin, 2002. PMID: None.
- Strassburg A, Kovtiz CA. A critical analysis of laboratory evaluations for hereditary thrombophilia at Keesler Medical Center. Society of Air Force Physicians Annual Meeting Bulletin, 2002. PMID: None.
- Baldwin S, Kovtiz CA. A critical analysis of the use of COX-2 inhibitors at Keesler Medical Center. Society of Air Force Physicians Annual Meeting Bulletin, 2002. PMID: None.
Book Chapters
- Kovitz C, Spiess PE, Tannir NM. Testicular Cancer. In: Encyclopedia of Cancer. 2nd. Springer-Verlag, 3656-3660, 2008.
- Kovitz CA, Millikan R, Logothetis C. Testicular Cancer. In: The M.D. Anderson Manual of Medical Oncology. 6th. McGraw-Hill, Medical Pub, 2006.
Patient Reviews
CV information above last modified December 19, 2024